Candriam SCA’s AngioDynamics ANGO Stock Holding History

Candriam SCA’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,009	Closed	-$371K	–	726
2023 Q1	$371K	Sell	39,009 -34,384	-47%	-$440K	﹤0.01%	834
2022 Q4	$1.01M	Buy	73,393 +27,182	+59%	+$378K	0.01%	695
2022 Q3	$946K	Buy	+46,211	New	+$1.01M	0.01%	721
2021 Q2	–	Sell	-102,687	Closed	-$1.51M	–	891
2021 Q1	$1.51M	Hold	102,687	–	–	0.01%	568
2020 Q4	$1.57M	Sell	102,687 -22,313	-18%	-$283K	0.01%	580
2020 Q3	$1.51M	Hold	125,000	–	–	0.01%	538
2020 Q2	$1.27M	Buy	125,000 +55,000	+79%	+$567K	0.01%	562
2020 Q1	$1.1M	Hold	70,000	–	–	0.01%	637
2019 Q4	$1.12M	Hold	70,000	–	–	0.01%	655
2019 Q3	$1.29M	Hold	70,000	–	–	0.02%	562
2019 Q2	$1.37M	Hold	70,000	–	–	0.02%	595
2019 Q1	$1.6M	Buy	70,000 +14,000	+25%	+$304K	0.02%	547
2018 Q4	$1.13M	Hold	56,000	–	–	0.02%	569
2018 Q3	$1.22M	Hold	56,000	–	–	0.02%	587
2018 Q2	$1.25M	Hold	56,000	–	–	0.02%	570
2018 Q1	$966K	Hold	56,000	–	–	0.02%	604
2017 Q4	$931K	Hold	56,000	–	–	0.02%	596
2017 Q3	$957K	Buy	+56,000	New	+$941K	0.02%	573

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Candriam SCA's ANGO Position: Q2 2023 in Review

Candriam SCA sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 39,009 shares — an estimated $371K sold.

Candriam SCA first reported a position in ANGO in Q3 2017 and held it in 18 quarters. The position peaked at $1.6M in Q1 2019. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

Candriam SCA reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 39,009 AngioDynamics shares in Q2 2023, an estimated $371K.
Candriam SCA first reported a position in AngioDynamics in Q3 2017 and held it in 18 quarters.
Candriam SCA's AngioDynamics position peaked at $1.6M in Q1 2019.
156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.